Benign breast disease: When to treat, when to reassure, when to refer

Cleveland Clinic Journal of Medicine

Volumn 69, Issue 5, 2002, Pages 425-432

  Vaidyanathan, Lakshmi ^a   Barnard, Karen ^a   Elnicki, D Michael ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CONTRACEPTIVE AGENT; DANAZOL; DIURETIC AGENT; ESTROGEN DERIVATIVE; MEDROXYPROGESTERONE; PRIMROSE OIL; PROGESTERONE DERIVATIVE; TAMOXIFEN;

ACNE; BREAST CANCER; BREAST DISCHARGE; BREAST DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIET; EDEMA; FEMALE; HUMAN; MAMMOGRAPHY; MASTALGIA; MASTITIS; PATIENT REFERRAL; PHYSICIAN; REVIEW; SCREENING TEST; SIDE EFFECT; SUBCUTANEOUS NODULE; SYMPTOMATOLOGY; WEIGHT GAIN;

EID: 0036079572     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.69.5.425     Document Type: Review

References (39)

1. Benign breast disease
2. Breast symptoms among women enrolled in a health maintenance organization: Frequency, evaluation, and outcome
3. The management of women with breast symptoms referred to secondary care clinics in Sheffield: Implications for improving local services
4. Fibrocystic "disease" of the breast - A nondisease?
5. Risk factors for breast cancer in women with proliferative breast disease
6. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia
7. Office management of benign breast disease
8. Breast disease in adolescents and young women
9. Clinical problems: Breast disease
10. The presentation and management of breast symptoms in general practice in South Wales
11. Value of breast imaging in women with painful breasts: Observational follow-up study
12. Mastalgia
13. The long-term course of mastalgia
14. The evaluation of common breast problems
15. Management of breast pain
16. The effect of decreased caffeine consumption on benign breast disease: A randomized clinical trial
17. Vitamin E and benign breast "disease": A double-blind, randomized clinical trial
18. Medical management of mammary dysplasia
19. European multicentre trial of bromocriptine in cyclical mastalgia
20. Fibrocystic breast disease: Pathophysiology, pathomorphology
21. Mastalgia and total body water
22. Breast masses in young women
23. The palpable breast lump: Information and recommendations to assist decision-making when a breast lump is detected
24. Palpable solid breast masses: Retrospective single and multimodality evaluation of 201 lesions
25. Immediate cytodiagnosis and imaging in the clinical management of discrete benign breast lesions
26. Evaluation of a palpable breast mass
27. Non-lactational nipple discharge
28. The significance of nipple discharge: Diagnosis and treatment regimes
29. Galactorrhea: A study of 235 cases, including 48 with pituitary tumors
30. Mastitis
31. Mondor's disease in the breast
32. Probably benign breast lesions: When should follow-up be recommended and what is the optimal follow-up protocol?
33. Nonpalpable, well-defined, probably benign breast nodule: Management by fine-needle aspiration biopsy and long-interval follow-up mammography
34. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR
35. P53 expression in patients with malignant and benign breast diseases
36. Her-2/neu amplification in benign breast disease and the risk of subsequent breast cancer
37. New screening techniques for breast cancer (MRI)
38. Breast disease: Dynamic spiral MR imaging
39. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women